Four recent clinical research organization (CRO) acquisitions and mergers have indicated a growing trend among biotech manufacturing companies. Charles River acquired Cognate Bioservices, Catalent Paragon acquired Delphi, WuXi Advanced Therapies acquired Oxgene, and Wacker Biotech acquired Genopsis.
DID YOU KNOW
Nanoplasmid Enhances DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus
Nanoplasmid increases efficacy of DNA Vaccines for Venezuelan Equine Encephalitis Virus and Ebola Virus
See how Poseida Therapeutics is utilizing the “dual benefits” of our Nanoplasmid™ vector for success
Data from their ongoing Phase 1 expansion trial using Nanoplasmid demonstrated an improvement in efficacy over standard plasmid and a potentially best-in-class safety profile.